Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab ; volume:27 ; number:1 ; day:4 ; month:11 ; year:2022 ; pages:61-74 ; date:1.2023
Molecular diagnosis & therapy ; 27, Heft 1 (4.11.2022), 61-74, 1.2023
- Urheber
-
Cammett, Tobin J.
Garlo, Katherine
Millman, Ellen E.
Rice, Kara
Toste, Catherine M.
Faas, Susan J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40291-022-00620-3
- URN
-
urn:nbn:de:101:1-2405130901164.896253085821
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cammett, Tobin J.
- Garlo, Katherine
- Millman, Ellen E.
- Rice, Kara
- Toste, Catherine M.
- Faas, Susan J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Thrombotic microangiopathy (TMA) associated with pregnancy: role of the clinical laboratory in differential diagnosis
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Thrombotic Microangiopathy in the Renal Allograft : Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
TMA
TMA
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Thrombotic microangiopathy (TMA) associated with pregnancy: role of the clinical laboratory in differential diagnosis
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Thrombotic Microangiopathy in the Renal Allograft : Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
TMA
TMA
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Thrombotic microangiopathy (TMA) associated with pregnancy: role of the clinical laboratory in differential diagnosis
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Thrombotic Microangiopathy in the Renal Allograft : Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
TMA